Symptom-Triggered Testing Persistent severe abdominal pain: urgent evaluation, lipase testing, and appropriate imaging Right-upper-abdominal pain or jaundice: liver and biliary testing plus gallbladder imaging Persistent vomiting or diarrhea: kidney function and electrolyte testing Symptoms of hypoglycemia: immediate glucose evaluation Fatigue or signs of deficiency: CBC and selected nutritional tests Testing should not delay medical care for severe symptoms
However, practitioners should counsel patients that this daily fasting requirement may present a practical barrier for some
At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below
Rotating injection sites between the abdomen, thigh, and upper arm helps minimize this issue
However, for qualified patients, they may help support appetite control, earlier fullness, reduced food intake, and greater consistency with a medical weight-loss plan
What is the evidence that these drugs are worth it long term